QIAGEN N.V. (QGEN) Stock Fundamental Analysis
USA - NYSE:QGEN - NL0015002CX3 - Common Stock
43.23 USD
-0.33 (-0.76%)
Overall QGEN gets a fundamental rating of 6 out of 10. We evaluated QGEN against 58 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QGEN a very profitable company, without any liquidiy or solvency issues. QGEN has a decent growth rate and is not valued too expensively. With these ratings, QGEN could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
QGEN had a positive operating cash flow in the past year.
Each year in the past 5 years QGEN has been profitable.
QGEN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.41%, QGEN belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
With an excellent Return On Equity value of 10.65%, QGEN belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
QGEN has a Return On Invested Capital of 8.66%. This is amongst the best in the industry. QGEN outperforms 81.03% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for QGEN is significantly below the industry average of 13.58%.
The last Return On Invested Capital (8.66%) for QGEN is above the 3 year average (7.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROIC | 8.66% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QGEN's Profit Margin of 18.30% is amongst the best of the industry. QGEN outperforms 91.38% of its industry peers.
QGEN's Profit Margin has declined in the last couple of years.
QGEN has a better Operating Margin (26.86%) than 94.83% of its industry peers.
QGEN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.18%, QGEN belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QGEN is creating some value.
QGEN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, QGEN has less shares outstanding
The debt/assets ratio for QGEN has been reduced compared to a year ago.
2.2 Solvency
QGEN has an Altman-Z score of 3.85. This indicates that QGEN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.85, QGEN is doing good in the industry, outperforming 74.14% of the companies in the same industry.
The Debt to FCF ratio of QGEN is 2.91, which is a good value as it means it would take QGEN, 2.91 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of QGEN (2.91) is better than 82.76% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that QGEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, QGEN is in line with its industry, outperforming 51.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Altman-Z | 3.85 |
ROIC/WACC1.1
WACC7.85%
2.3 Liquidity
QGEN has a Current Ratio of 1.61. This is a normal value and indicates that QGEN is financially healthy and should not expect problems in meeting its short term obligations.
QGEN's Current ratio of 1.61 is on the low side compared to the rest of the industry. QGEN is outperformed by 63.79% of its industry peers.
QGEN has a Quick Ratio of 1.35. This is a normal value and indicates that QGEN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of QGEN (1.35) is worse than 65.52% of its industry peers.
The current and quick ratio evaluation for QGEN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
QGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.62%, which is quite good.
QGEN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
The Revenue has been growing slightly by 0.66% in the past year.
QGEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.32% yearly.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
Based on estimates for the next years, QGEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.80% on average per year.
Based on estimates for the next years, QGEN will show a small growth in Revenue. The Revenue will grow by 7.89% on average per year.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.24, QGEN is valued on the expensive side.
Based on the Price/Earnings ratio, QGEN is valued cheaper than 89.66% of the companies in the same industry.
QGEN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.66, the valuation of QGEN can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 89.66% of the companies listed in the same industry.
QGEN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 32.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.24 | ||
| Fwd PE | 16.66 |
4.2 Price Multiples
QGEN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QGEN is cheaper than 93.10% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 86.21% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.9 | ||
| EV/EBITDA | 13.19 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QGEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.13
PEG (5Y)2.17
EPS Next 2Y8.08%
EPS Next 3Y8.5%
5. Dividend
5.1 Amount
QGEN has a yearly dividend return of 0.57%, which is pretty low.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.49. QGEN pays more dividend than 94.83% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.57% |
5.2 History
QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
NYSE:QGEN (11/10/2025, 3:54:54 PM)
43.23
-0.33 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.95%
Inst Owner Change-7.64%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap9.37B
Revenue(TTM)1.98B
Net Income(TTM)373.39M
Analysts74.17
Price Target52.09 (20.5%)
Short Float %2.82%
Short Ratio5.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.57% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.51%
EPS beat(12)8
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)5.44%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)-0.56%
PT rev (3m)1.07%
EPS NQ rev (1m)-0.31%
EPS NQ rev (3m)0.3%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)1.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.24 | ||
| Fwd PE | 16.66 | ||
| P/S | 4.59 | ||
| P/FCF | 18.9 | ||
| P/OCF | 13.89 | ||
| P/B | 2.67 | ||
| P/tB | 14.66 | ||
| EV/EBITDA | 13.19 |
EPS(TTM)2.37
EY5.48%
EPS(NY)2.6
Fwd EY6%
FCF(TTM)2.29
FCFY5.29%
OCF(TTM)3.11
OCFY7.2%
SpS9.41
BVpS16.17
TBVpS2.95
PEG (NY)2.13
PEG (5Y)2.17
Graham Number29.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROCE | 11.67% | ||
| ROIC | 8.66% | ||
| ROICexc | 10.87% | ||
| ROICexgc | 46.44% | ||
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% | ||
| FCFM | 24.31% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 94.78% | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.61% | ||
| Profit Quality | 132.83% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 3.85 |
F-Score8
WACC7.85%
ROIC/WACC1.1
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
EBIT growth 1Y21.82%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QGEN FAQ
Can you provide the ChartMill fundamental rating for QIAGEN N.V.?
ChartMill assigns a fundamental rating of 6 / 10 to QGEN.
What is the valuation status of QIAGEN N.V. (QGEN) stock?
ChartMill assigns a valuation rating of 6 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.
What is the profitability of QGEN stock?
QIAGEN N.V. (QGEN) has a profitability rating of 8 / 10.
What are the PE and PB ratios of QIAGEN N.V. (QGEN) stock?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QGEN) is 18.24 and the Price/Book (PB) ratio is 2.67.